1. Home
  2. QUAD vs CERS Comparison

QUAD vs CERS Comparison

Compare QUAD & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$6.61

Market Cap

336.6M

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$1.79

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
CERS
Founded
1971
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
EDP Services
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
336.6M
276.0M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
QUAD
CERS
Price
$6.61
$1.79
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9.90
N/A
AVG Volume (30 Days)
250.3K
2.1M
Earning Date
04-28-2026
03-02-2026
Dividend Yield
6.24%
N/A
EPS Growth
150.47
27.27
EPS
0.54
N/A
Revenue
$2,419,900,000.00
$51,326,000.00
Revenue This Year
N/A
$20.00
Revenue Next Year
N/A
$9.60
P/E Ratio
$11.87
N/A
Revenue Growth
N/A
30.68
52 Week Low
$4.50
$1.12
52 Week High
$7.54
$2.96

Technical Indicators

Market Signals
Indicator
QUAD
CERS
Relative Strength Index (RSI) 49.98 36.41
Support Level $6.40 $1.37
Resistance Level $6.74 $2.26
Average True Range (ATR) 0.25 0.15
MACD -0.06 -0.03
Stochastic Oscillator 43.75 15.57

Price Performance

Historical Comparison
QUAD
CERS

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: